|
KMID : 1011920110120020004
|
|
International Journal of Arrhythmia
2011 Volume.12 No. 2 p.4 ~ p.6
|
|
|
Management of SVT (Medical treatment)
|
|
Yoon Nam-Sik
|
|
|
Abstract
|
|
|
|
Paroxysmal supraventricular tachycardia, PSVT, involves the AV node for occurrence and maintenance of tachycardia and responds to AV nodal blocking agent such as adenosine, calcium-channel blocker (verapamil, diltiazem) and beta-blocker (propranolol, esmolol). Medication is given for patients with frequent recurrences and critical symptoms in order to prevent repetition. The medication (anti-arrhythmic agent) schedule is decided upon according to the mechanism of the PSVT, the performance status of the patient, the electrophysiological characteristics of drug and how much the physician is familiar with the medication.
|
|
|
KEYWORD
|
|
|
paroxysmal supraventricular tachycardia, anti arrhythmic agent
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|